Claturafenib

N/A

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameClaturafenib
Drug Alias NamePF-07799933ARRY-440
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsHigh-Grade GliomaLow-grade GliomaSolid tumours +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer (China) Research And Development Co LtdPfizer Inc
Inactive CompaniesN/A
Active IndicationsHigh-Grade GliomaLow-grade GliomaSolid tumours +[9] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A